Gregg M. Gellman Appointed CEO of Open Implants: Offers Deep Medical Device Development & Manufacturing Business Development Experience

Burgeoning Demand for MRI-guided Radiation Therapy Systems Market to Fuel Market Growth Thorough the COVID-19 Crisis Period

The relatively new technology for integrating magnetic resonance imaging (MRI) with radiation therapy is becoming increasingly prevalent, with revenues from the MRI-guided radiation therapy systems market exceeding US$ 220 Mn in 2018, according to a recent study by Fact.MR.

COVID-19 to Substantially Increase the Demand for 3D Printing Medical Devices Market from Key End-use Industry Sectors Unveils Fact.MR

The global 3D printing medical devices market is expected to exceed US$ 1,700 Mn in revenues by 2022-end, according to a recent research by Fact.MR.

DOORwaY-90 Study for SIR-Spheres® Therapy as 1st-line Treatment for Hepatocellular Carcinoma Enrolls First Patient

The study will assess the duration of response (DoR) and objective response rate (ORR) of SIR-Spheres. It is being led by co-principal investigators Cheenu Kappadath, PhD and Dr. Armeen Mahvash.

February 3, 2021

Gregg M. Gellman has more than 15 years of experience, leading and growing biomedical companies. He brings a unique and strong skill set to the company.

Gellman’s previous experience includes executive leadership roles at EBI Biomet, now Zimmer Biomet, Greatbatch now Integer Holdings, EnerMed now Garwood Medical, StimMed and Thinking Robot Studios where he will continue to serve as a Board Member for both companies. He has a proven track record in product development, commercialization of regulated applications/products, regulatory and sales. Gellman is a graduate of the State University of New York at Buffalo. He is certified in Quality Systems for Medical Devices (FDA’s QSR and ISO 13485) and in Global Product Submissions Directive Requirements (510(k), PMA, CE Mark).

Greg M. Gellman feels this is a tremendous opportunity to contribute to building on what Open Implants has already accomplished. “My roots are in orthopedics, regulated manufacturing and advanced technologies and I look forward to working with customers and the Open Implants team to accelerate product development and increase our commitments to insure customer satisfaction and above all positive clinical outcomes for patients who require dental surgery.”

Rob Nazzal, Co-founder and Board Member, says, “Gregg’s deep experience in medical device development, manufacturing, and business development, will be an enormous asset for Open Implants. With Gregg onboard, we are accelerating our roadmap to deliver more comprehensive solutions to the evolving digital dentistry world. We are privileged to have Gregg on our team.”

Gregg M. Gellmen succeeds Frederic Rapp, who is also a co-founder of Open Implants. Rapp will continue as a member of the Board of Directors and will also continue full-time leadership of his dental laboratory, CrownCeram, in France.

spot_img

DON'T MISS

Subscribe to Medical Device News Magazine here.

Related Articles